See a U.S. licensed physician by phone or video. Access consented regenerative medicine, research and investigational therapies, and consented TOL oleander treatment, with a 16-year manufacturing record and 19,000-plus subjects served in research and investigational settings.

Every pathway runs on signed informed consent, physician supervision, and a complete chain of custody from manufacturer to patient.

Wharton's jelly derived exosome therapy, in-home IV infusions, and topical formulations. Each lot is paired with a cGMP Certificate of Analysis and a chain of custody log from the U.S. manufacturer to the bedside.

Participate in IRB-overseen research and investigational protocols delivered through TRM Health. All therapies referenced here are investigational and are not FDA-approved to treat any specific disease or condition.

TOL Protocol is a consented research and investigational use of oleander-derived material under physician supervision. Patients sign a TOL-specific informed consent that explains potential cardiac risks, contraindicated medications, and the strictly investigational nature of the therapy.
Sign in and book a phone or video visit. Intake is conditional and only collects what your protocol requires.
Review and sign the disease-specific consent (WJ Exosome, TOL, Home IV, Topicals) and the Texas 22 TAC 171.2(b) form where applicable.
Encounter is documented in real time. AI drafts a SOAP note. Your physician reviews, edits, and countersigns it.
Verified cGMP lot ships cold-chain to your home, or an RN performs the visit. You see every step in your portal.
TRM Health partners with a U.S.-based cGMP manufacturer with a 16-year operating record and a documented experience base of more than 19,000 subjects served across research and investigational service settings. Every shipment carries a lot Certificate of Analysis and a tamper-evident chain of custody log.
Therapies and protocols described on this page are investigational. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. See the full disclaimers.
Read full disclaimers
Same-week scheduling for most consented protocols.